Vaccine and prime-boost vaccine
AssigneeNihon University
InventorsShihoko AIZAWA, Mitsuo HONDA, Satoshi HAYAKAWA
Life of this patent
Estimating the term…
Abstract
A vaccine for activating CD8 T cells including Bacillus Calmette-Guérin (BCG bacteria) which express a protein derived from a pathogenic microorganism as an active ingredient is beneficial because it can activate pathogenic microorganism-derived-antigen-specific CD8 T cells
Claims8
A vaccine for activating CD8 T cells comprising Bacillus Calmette-Guérin (BCG bacteria) which express a protein derived from a pathogenic microorganism as an active ingredient.
A method of activating pathogenic microorganism-derived-antigen-specific CD8 T cells in a patient in need thereof, comprising a step of administering an effective amount of BCG bacteria expressing a protein derived from a pathogenic microorganism to the patient.
Dependencies are inferred from the claim text.